Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by deepoil0808on Oct 08, 2021 11:38am
150 Views
Post# 33988814

UnderReporting Revenue? July 2021 closer to $ 10 million???

UnderReporting Revenue? July 2021 closer to $ 10 million???I read the August 17th press release and it appears to me that the company may have under reported its actual revenue.   I will explain the discrepancy. 

Here are the calculations I made from the press release:


For June 2021 month:
- 5,077 patients per week at 4 weeks = 20,308 patients in the month of June
- $ 298,740 revenue per week at 4 weeks =  $ 1,194,960 in month of June 

Therefore we can calculate that the price per patient was $ 58.84   ($1,194,960 / 20,308)

The press release states that the average price charged was $ 58 per patient, which is really one (1) test


For July 2021 month

There is an explosion in revenue, patients and prices.    They now only do 3 tests.

- 16,794 patients per week at 4 weeks =  67,176 patients in month of July 2021
- $ 1,005,050 revenue per week at 4 weeks =  $ 4,020,020 in month of July 2021

Therefore we can calculate that the price per patient was $ 59.84 ($4,020,020 /67,176), amounts to one (1) test.

BUT, the press release clearly states that the average weekly price has increased to $ 150 per patient, which is for 3 tests.   It is not $ 59,84 per one test.   

We also know that website says 3 tests for $ 150 and, California authorities have confirmed long lineups with prices charged at $ 150 per patient.

Per my caculation, revenue should be much higher in July 2021 than actually reported, somewhere in the range of $10 million (67,176 patients in July 2021 at $ 150 each)  and, not $ 4 million (67,176 patients at $59.84 each in July 2021).

Is the company intentionally UNDER REPORTING its actual revenue or, did they make an error in reporting their total numbers????

This is my two cents

<< Previous
Bullboard Posts
Next >>